Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab.

Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz; Koneth, Irene; Binet, Isabelle; Kremer Hovinga, Johanna A. (2019). Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. American journal of hematology, 94(10), E259-E261. Wiley-Liss 10.1002/ajh.25583

[img] Text
Robertz_et_al-2019-American_Journal_of_Hematology.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (533kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)

UniBE Contributor:

Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz and Kremer Hovinga, Johanna Anna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0361-8609

Publisher:

Wiley-Liss

Language:

English

Submitter:

Pierrette Durand Lüthi

Date Deposited:

23 Sep 2019 10:22

Last Modified:

23 Oct 2019 08:50

Publisher DOI:

10.1002/ajh.25583

PubMed ID:

31321811

BORIS DOI:

10.7892/boris.133383

URI:

https://boris.unibe.ch/id/eprint/133383

Actions (login required)

Edit item Edit item
Provide Feedback